On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
MondayJan 30, 2017 2:30 pm

SeaChange International, Inc. (NASDAQ: SEAC) Starts Presentation at NobleCon13

SeaChange (NASDAQ: SEAC) provides multiscreen video products and services that facilitate the aggregation, licensing, management and distribution of video and television advertising content to cable system operators, satellite operators, and telecommunications and media companies worldwide. The company offers multiscreen video products, including SeaChange Adrenalin, a multiscreen back office platform that enables service providers to manage, monetize and deliver a seamless viewing experience across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and SeaChange AssetFlow, which is used to receive, manage, and publish content for on-demand viewing on televisions, tablets, PCs and other consumer devices. For more information,…

Continue Reading

MondayJan 30, 2017 2:30 pm

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at NobleCon13

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor…

Continue Reading

MondayJan 30, 2017 2:27 pm

How will Time’s Adelphic acquisition affect the Ad Tech Industry?

Time’s Adelphic acquisition may signal the beginning of a new Ad Tech arms race Companies mentioned in this article: Time, Inc. (NYSE: TIME), Social Reality, Inc. (NASDAQ: SRAX), Adobe Systems, Inc. (NASDAQ: ADBE), Facebook (NASDAQ: FB), Alphabet (NASDAQ: GOOG) and Yahoo (NASDAQ: YHOO) When Time, Inc. (NYSE: TIME) acquired Viant, a data-centric marketing company, last year, many observers wondered just how it planned on monetizing the 1 billion, plus, strong registered user database, but its recently announced plans to acquire Adelphic just filled in the gaps. Adelphic is an innovative demand-side platform (DSP) cross-channel programmatic advertising platform provider, which includes…

Continue Reading

MondayJan 30, 2017 2:00 pm

Innodata, Inc. (NASDAQ: INOD) Starts Presentation at NobleCon13

Innodata (NASDAQ: INOD) provides technology solutions and services worldwide, operating through three segments: Content Services (CS), Innodata Advanced Data Solutions (IADS), and Media Intelligence Solutions (MIS). The CS segment produces and distributes e-books, develops new digital information products, and provides operational support services for existing digital information products and systems, including content aggregation, extraction, encoding, indexing and abstracting, fabrication, and distribution. The IADS segment offers services that enable clients in the financial services, insurance, medical and healthcare sectors to enhance decision-support through digital technologies. For more information, visit the company’s website at www.innodata.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayJan 30, 2017 2:00 pm

Salem Media Group (NASDAQ: SALM) Starts Presentation at NobleCon13

Salem Media (NASDAQ: SALM) operates as a multi-media company in the United States. The company owns and operates radio networks, which produce and distribute talk, news and music programming to radio stations in the United States, as well as sells commercial airtime to national advertisers and independent radio station affiliates. It also provides Christian and conservative-themed content, audio and video streaming, and other resources digitally through Christian content websites, such as OnePlace.com, Christianity.com, Crosswalk.com, GodVine.com, Jesus.org, and BibleStudyTools.com; and conservative opinion Websites, such as Townhall.com, HotAir.com, Twitchy.com, HumanEvents.com, and RedState.com.  For more information, visit the company’s website www.salem.cc. About NetworkNewsWire…

Continue Reading

MondayJan 30, 2017 2:00 pm

Great Panther Silver Limited (NYSE: GPL) Starts Presentation at NobleCon13

Great Panther Silver (NYSE: GPL) is a primary silver mining and exploration company listed on the Toronto Stock Exchange trading under the symbol GPR, and on the NYSE MKT trading under the symbol GPL. Great Panther's current activities are focused on the mining of precious metals from its two wholly-owned operating mines in Mexico: the Guanajuato Mine Complex, which includes the San Ignacio Mine, and the Topia Mine in Durango. In addition, the company has recently signed an agreement to acquire a 100% interest in the Coricancha Mine Complex in the central Andes of Peru. For more information, visit the…

Continue Reading

MondayJan 30, 2017 2:00 pm

Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) Starts Presentation at NobleCon13

Eyegate Pharmaceuticals (NASDAQ: EYEG) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EGP-437, the company’s first product in clinical trials, incorporates a reformulated topically active corticosteroid that is delivered into the ocular tissues through EyeGate’s proprietary innovative drug delivery system, the EyeGate® II Delivery System. In addition, the company is developing, through its wholly owned Jade subsidiary, products using cross-linked thiolated carboxymethyl hyaluronic acid (“CMHA-S”), a modified form of the natural polymer hyaluronic acid (HA), which possesses unique physical and chemical properties such as hydration and healing properties.…

Continue Reading

MondayJan 30, 2017 1:39 pm

NetworkNewsWire Provides Real-time Coverage of NobleCon13 Investor Conference

NetworkNewsWire (“NNW”) is providing real-time coverage of Noble Financial’s ongoing 13th Annual Small Cap & Emerging Growth Investor Conference, NobleCon13. Taking place January 30-31 in Boca Raton, Florida, NobleCon13 provides a forum where public and private emerging growth companies from a wide array of industries can meet with fund managers and high net worth investors who focus on small-cap equities. As a multifaceted financial news and publishing company, NNW is leveraging its vast distribution capabilities to provide a brief business overview on each publicly traded company as it takes the stage to present to attending investors. To view the list…

Continue Reading

MondayJan 30, 2017 1:30 pm

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) Starts Presentation at NobleCon13

Five Prime Therapeutics (NASDAQ: FPRX) is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008 in phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; phase I/II clinical trials for the treatment of pigmented villonodular synovitis tumor; and phase I clinical trials for the treatment of rheumatoid arthritis. Its product candidates also comprise FPA144, an antibody that inhibits fibroblast growth factor receptor IIb and is in phase I clinical trials to treat patients with…

Continue Reading

MondayJan 30, 2017 1:30 pm

ITUS Corp. (NASDAQ: ITUS) Starts Presentation at NobleCon13

ITUS (NASDAQ: ITUS) funds, develops, acquires and licenses emerging technologies in the areas of biotechnology. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek, a series of non-invasive, blood tests for the early detection of solid tumor based cancers. It has a collaborative research agreement with The Wistar Institute for the development and validation of Cchek. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. For more information, visit the company’s website at www.ituscorp.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

Contact us: 212.418.1217